{"schema_version":"secwatch.filing_event.v1","accession":"0001641172-25-013417","form_type":"8-K","ticker":"IMMX","cik":"0001873835","company_name":"Immix Biopharma, Inc.","filed_at":"2025-06-03T23:59:59+00:00","discovered_at":"2026-05-14T18:02:50.320960+00:00","generated_at":"2026-05-20T01:58:22.230552+00:00","sec_items":["1.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Immix Biopharma enters ATM equity offering with Citizens JMP Securities","bullets":["Agreement allows at-the-market sales of common stock; 3% commission to Agent.","Sales conducted under existing S-3 shelf (File No. 333-269100), filed January 2023.","No immediate sale; company controls timing, price, and size of any offerings.","Agent indemnified and reimbursed up to $50,000 for specified expenses.","Shares subject to registration limits and Nasdaq rules."],"urls":{"canonical":"https://secwatch.observer/filing/0001641172-25-013417","json":"https://secwatch.observer/filing/0001641172-25-013417.json","markdown":"https://secwatch.observer/filing/0001641172-25-013417.md","text":"https://secwatch.observer/filing/0001641172-25-013417.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1873835/000164117225013417/0001641172-25-013417-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1873835/000164117225013417/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-20T01:58:22.230552+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}